Similar Search Results

Battle royal in biotechnology : R&D vs. product vs. process innovations

Nicolau, Juan Luis; Santa Maria, María Jesús - In: Technology analysis & strategic management 27 (2015) 5, pp. 503-516

Persistent link: https://www.econbiz.de/10010517243

Bridging the social chasm in geographically distributed R&D teams : the moderating effects of relational strength and status asymmetry on the novelty of team innovation

Tzabbar, Daniel; Vestal, Alex - In: Organization science : a journal of the Institute for … 26 (2015) 3, pp. 811-829

Persistent link: https://www.econbiz.de/10011289864

Debates on food technologies in India : R&D priorities, production trends and growing expectations

Chaturvedi, Sachin - 2014

Persistent link: https://www.econbiz.de/10011300510

Biotechnology : can the transatlantic trade and investment partnership reconcile EU and US differences on GMOs?

Chereau, Claude J. - In: International journal of trade and global markets 7 (2014) 4, pp. 316-338

Persistent link: https://www.econbiz.de/10011311799

Investigating the determinants of patent acquisition in biotechnology : an empirical analysis

Messeni Petruzzelli, Antonio; Natalicchio, Angelo; … - In: Technology analysis & strategic management 27 (2015) 7, pp. 840-858

Persistent link: https://www.econbiz.de/10011317257

Distinguishing between spinouts and non-spinouts : allocating control rights in biotechnology alliances

Kim, Jongwook; Madunic, Marko - In: International journal of learning and intellectual … 11 (2014) 4, pp. 334-356

Persistent link: https://www.econbiz.de/10011318098

CEO narcissism, audience engagement, and organizational adoption of technological discontinuities

Gerstner, Wolf-Christian; König, Andreas; Enders, Albrecht - In: Administrative science quarterly : ASQ ; dedicated to … 58 (2013) 2, pp. 257-291

Persistent link: https://www.econbiz.de/10009754689

Profiting from technological capabilities : Technology commercialization strategy in a dynamic context

Wakeman, Simon - 2010

This paper analyzes the technology commercialization strategy of an innovating firm when the incumbent firms possess specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong appropriabilty regime the optimal strategy is to...

Persistent link: https://www.econbiz.de/10010357556

Can’t buy me rights! : the contractual structure of asymmetrical inter-firm collaborations

Häussler, Carolin - 2006

biotechnology and pharmaceutical firms. Fifteen control rights are identified to make up the structure of deals with five rights …

Persistent link: https://www.econbiz.de/10010383035

Cluster performance reconsidered : structure, linkages and paths in the German biotechnology industry, 1996-2003

Häussler, Carolin; Zademach, Hans-Martin - 2006

This paper addresses the evolution of biotechnology clusters in Germany between 1996 and 2003, paying particular … attention to their respective composition in terms of venture capital, basic science institutions and biotechnology firms …

Persistent link: https://www.econbiz.de/10010383036

A service of the

zbw